We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Smith-Magenis Syndrome Traced to Single Gene Mutation

By Biotechdaily staff writers
Posted on 03 Apr 2003
A study has shown that the retionic acid induced 1 (RAI1) gene located on chromosome 17p11.2 is responsible for the developmental disorder known as Smith-Magenis syndrome (SMS). More...
The study was published March 24, 2003, in the online edition of Nature Genetics.

SMS, which occurs in approximately one of every 25,000 births, is a chromosome microdeletion syndrome characterized by a distinct series of physical, developmental and behavioral features, including varying levels of mental retardation, cranio-facial abnormalities, sleep disturbances and self-injurious behaviors.

Since SMS is normally associated with a chromosomal deletion that includes many genes, it was assumed that more than one gene contributed to the disorder. However, in the current study investigators from Michigan State University (East Lansing, USA) found that the syndrome could be traced to the mutation of a single gene.

"The result of this mutation is that the protein cannot be formed properly,” explained senior author Dr. Sarah Elsea, an assistant professor in the departments of pediatrics and human development and zoology at Michigan State University. "Individuals with SMS have one normal functioning RAI1 protein from one chromosome, but from the other chromosome they are not getting this protein function at all. I think that in the future, if we understand what this gene, this protein, does and how it interacts with other proteins in the cell, we might be able to develop some kind of drug therapy that might help deal with the behaviors a little better.”



Related Links:
Michigan State University

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Thyroid Test
Anti-Thyroid EIA Test
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.